Do oral ovulation induction agents offer benefits in women 38 to 43 years of age undergoing insemination cycles?

In: European Journal of Obstetrics & Gynecology and Reproductive Biology · 2021 · vol. 258 , pp. 273–277 · doi:10.1016/j.ejogrb.2021.01.012 · PMID:33486239 · W3120219503
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
AI-generated summary by claude@2026-06, 2026-06-08

This study investigated whether oral ovulation induction agents provide any benefit to women aged 38-43 undergoing insemination cycles.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (15)

Source provenance

openalex
last seen: 2026-05-11T05:40:41.230350+00:00
License: CC0 · commercial use OK